Atea Pharmaceuticals share price logo

Atea Pharmaceuticals

NASDAQ: AVIR

Small Cap

$5.28

+0.06

(+1.05%)

as on

Atea Pharmaceuticals Stock Performance

as on August 19, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $5.14
    $5.30
    downward going graph

    2.65%

    Downside

    0.38%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.78
    $6.45
    downward going graph

    47.35%

    Downside

    22.16%

    Upside

    downward going graph

Atea Pharmaceuticals share price movements today

Previous Close
$5.22
Open
$5.22
Volume
338.7K
Market Cap
$410.6M
Day's Low - High
$5.14 - $5.30
52 Week Low - High
$2.78 - $6.45

Atea Pharmaceuticals Historical Returns

1 Month Return
+ 5.13 %
3 Month Return
+ 24.88 %
1 Year Return
+ 46.29 %
3 Year Return
+ 50.59 %
5 Year Return
-82.19 %

Atea Pharmaceuticals Stock Fundamentals & Key Indicators

Check Atea Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$410.6M

EPS (TTM)

-2.08

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

2.64%

PE Ratio (TTM)

-2.44

Industry PE ratio

-7.283372093023256

PEG Ratio

0.09882070348689134

EBITDA

-171.3M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-64.25%

Atea Pharmaceuticals Stock Valuation

Track how Atea Pharmaceuticals P/E has moved over time to understand its valuation trends.

Atea Pharmaceuticals in the last 5 years

  • Overview

  • Trends

Lowest (-3.45x)

December 31, 2022

Industry (-7.28x)

December 31, 2025

Today (-1.84x)

December 31, 2025

Highest (6.11x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: -1.84x

Atea Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Atea Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
SELL$410.6M-82.19%-2.440.00%NA
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for Atea Pharmaceuticals Stock including INR - Dollar returns

The Atea Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Atea Pharmaceuticals investment value today

Current value as on today

₹1,65,300

Returns

₹65,300

(+65.3%)

Returns from Atea Pharmaceuticals Stock

₹50,857 (+50.86%)

Dollar Impact

₹14,443 (+14.44%)

Analyst Recommendation on Atea Pharmaceuticals Stock

Based on 2 analysts

SELL

50.00%

Buy

50.00%

Hold

0.00%

Sell

Based on 2 analysts, 50% of analysts recommend a 'SELL' rating for Atea Pharmaceuticals. Average target price of $9.42

Atea Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on Atea Pharmaceuticals.

What analysts predicted

43.95%UPSIDE

Target Price

$9.42

Current Price

$5.28

Analyzed by

2 Analysts

Target

$9.42

Atea Pharmaceuticals target price $9.42, a slight upside of 43.95% compared to current price of $5.28. According to 2 analysts rating.

Indian Investors' Interest in Atea Pharmaceuticals Stock

Search interest for Atea Pharmaceuticals Stock has increased by 28% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:28% versus previous 30 day period

Atea Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
-19
0
-3
-2
-38
-
0
-
Operating Income
-69
-46
-37
-39
-39
-41
-45
-54
-48
-35
EBITDA
-62
-40
-30
-33
-33
-41
-41
-51
-45
-32
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-62
-40
-30
-33
-34
-36
-41
-51
-45
-32
Income Tax Expense
0
0
0
0
0
0
0
-6
0
0
Net Income
-63
-40
-31
-33
-34
-37
-42
-44
-45
-32
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Atea Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
48
351
-
-
-
-
Gross Profit
0
0
10
184
-62
-70
-83
-
Operating Income
-9
-14
-11
138
-130
-164
-192
-180
EBITDA
-9
-14
-11
138
-110
-119
-131
-164
Interest Expense
-
-
-
-
11
-
-
-
Depreciation
0
0
0
0
0
0
0
0
Income Before Tax
-9
-14
-10
138
-119
-134
-167
-164
Income Tax Expense
-
-
-
17
-3
1
0
-6
Net Income
-9
-13
-10
121
-115
-135
-168
-158
Net Profit Margin
0.00%
0.00%
21.82%
52.41%
0.00%
0.00%
0.00%
0.00%

Atea Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-63
-40
-31
-33
-34
-37
-42
-44
-45
-32
Operating Cash Flow
-39
-42
-23
-30
-30
-32
-40
-28
-46
-37
Investing Cash Flow
56
124
-122
-3
85
15
41
46
29
34
Financing Cash Flow
0
-
0
-
0
-14
-11
-
0
-
Change in Cash
17
82
-144
-33
54
-31
-10
18
-16
-2

Atea Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-9
-14
-10
121
-115
-135
-168
-158
Operating Cash Flow
-7
-12
296
-87
-120
-85
-135
-132
Investing Cash Flow
0
0
0
0
-455
40
56
188
Financing Cash Flow
27
0
531
1
0
0
0
-25
Change in Cash
19
-12
828
-85
-576
-44
-79
31

Mutual Funds that own Atea Pharmaceuticals Stock

Check out the Mutual Funds with significant holdings in Atea Pharmaceuticals.

Funds
Holdings
Shares Held
Fidelity Mt. Vernon Street Trust
5.484235%
4388875
VANGUARD INDEX FUNDS
3.970874%
3177776
Fidelity Salem Street Trust
0.984771%
788084
BlackRock Funds
0.95452%
763875
Fidelity Concord Street Trust
0.902799%
722484

Global Institutional Holdings in Atea Pharmaceuticals

Funds
Holdings
Xtrackers
0.09%
Dimensional
0.74%
Vanguard
4.41%
iShares
4.39%
Schwab
0.49%

Atea Pharmaceuticals News & Key Events

  • img

    Today's Timeline - 02 September

    Tue, 04:30 PM

    -

    Atea Pharmaceuticals to participate in Morgan Stanley Healthcare Conference on September 9, 2025.

Insights on Atea Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, AVIR stock has moved up by 3.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 615.7% return, outperforming this stock by 559.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 481.6% return, outperforming this stock by 433.7%

About Atea Pharmaceuticals

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections. Its lead product candidate is the regimen of bemnifosbuvir, a nucleotide NS5B inhibitor, and ruzasvir, an NS5A inhibitor, which is in Phase 3 clinical trial for the treatment of hepatitis C virus (HCV). The company also developing AT-587, that is in Phase 1 clinical trial for the treatment of chronic HEV infection. In addition, it offers a proprietary platform of nucleosides and nucleotides for virology, medicinal chemistry, and antiviral drug development. The company has a license agreement with MSD International GmbH for the development, manufacture, and commercialization of ruzasvir. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
OrganisationAtea Pharmaceuticals
Headquarters225 Franklin Street, Boston, MA, United States, 02110
IndustryBiotechnology
CEODr. Jean-Pierre Sommadossi Ph.D.
E-voting on sharesClick here to vote

Key Management of Atea Pharmaceuticals

Name

Title

Dr. Jean-Pierre Sommadossi Ph.D.

Founder, Chairman, CEO & President

Mr. Wayne Foster CPA

Executive VP of Finance & Chief Accounting Officer

Mr. Xiao-Jian Zhou Ph.D.

Executive Vice President of Early Stage Development

Mr. Keith Pietropaolo

Executive VP of Clinical Sciences & Project Management

Mr. Adel Moussa Ph.D.

Executive Vice President of Chemistry

Ms. Andrea J. Corcoran J.D.

CFO, Executive VP of Legal & Secretary

Mr. John F. Vavricka

Chief Commercial Officer

Dr. Janet M. J. Hammond M.D., Ph.D.

Chief Development Officer

Dr. Maria Arantxa Horga M.D.

Chief Medical Officer

Ms. Jonae R. Barnes

Senior Vice President of Investor Relations & Corporate Communications

FAQs

What is Atea Pharmaceuticals share price today?

Atea Pharmaceuticals share price today is $5.28 as on at the close of the market. Atea Pharmaceuticals share today touched a day high of $5.30 and a low of $5.14.

What is the 52 week high and 52 week low for Atea Pharmaceuticals share?

Atea Pharmaceuticals share touched a 52 week high of $6.45 on and a 52 week low of $2.78 on . Atea Pharmaceuticals stock price today i.e. is closed at $5.28,which is 18.14% down from its 52 week high and 89.93% up from its 52 week low.

What is Atea Pharmaceuticals's market capitalisation today?

Atea Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in Atea Pharmaceuticals Stock (AVIR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Atea Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Atea Pharmaceuticals Shares that will get you 0.2841 shares as per Atea Pharmaceuticals share price of $5.28 per share as on August 19, 2026 at 1:29 am IST.

What is the minimum amount required to buy Atea Pharmaceuticals Stock (AVIR) from India?

Indian investors can start investing in Atea Pharmaceuticals (AVIR) shares with as little as ₹95.67 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.70 in Atea Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on Atea Pharmaceuticals share’s latest price of $5.28 as on August 19, 2026 at 1:29 am IST, you will get 1.8939 shares of Atea Pharmaceuticals. Learn more about fractional shares .

What are the returns that Atea Pharmaceuticals has given to Indian investors in the last 5 years?

Atea Pharmaceuticals stock has given -82.19% share price returns and 28.34% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?